This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Type of economic evaluation
Cost-effectiveness analysis, cost-utility analysis
Study objective
This study examined the cost-effectiveness of raising the excise taxes on cigarettes in the entire US population of never smokers, current smokers, and former smokers.
Interventions
Various rates of tax-induced cigarette price increases were considered and compared with the current price (status quo).
Location/setting
USA/community.
Methods

Analytical approach:
This economic evaluation was based on a dynamic computer simulation model, which projected the smoking behaviour of the US population with and without tax increase over a 21-year time horizon (from 2004 to 2025). The authors did not explicitly report the perspective.
Effectiveness data:
The clinical data came from a selection of known, relevant sources such as the US Census bureau, the Behavioural Risk Factor Surveillance System (BRFSS) and Teenage Attitudes and Practice Survey, the Tobacco Use Supplement of the Current Population Survey, and the National Health Interview Survey. The details on these sources and the methods used to extract the primary data and then combine them were not reported. The key clinical input was the change in smoking prevalence, which was stratified by age groups, that resulted from price increases (price elasticity). This was calculated on the basis of individual level data from the BRFSS and other factors that are generally associated with the consumption of cigarettes.
Monetary benefit and utility valuations:
The utility values were derived from two published studies reporting the quality of life associated with smoking in adults (using the Quality of Well Being scale) and youth (using data from the National Health Interview Survey).
Measure of benefit:
Life-years (LYs) and quality-adjusted life-years (QALYs) were the summary benefit measures. The adult smoking prevalence was also reported as a key model output.
